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Paris, Paris, FranceAbstractInfectious agents associated with community-acquired pneumonia (CAP) are under-studied. This study attempted to identify viruses from the
upper respiratory tract in adults visiting emergency departments for clinically suspected CAP. Adults with suspected CAP enrolled in the
ESCAPED study (impact of computed tomography on CAP diagnosis) had prospective nasopharyngeal (NP) samples studied by multiplex
PCR (targeting 15 viruses and four intracellular bacteria). An adjudication committee composed of infectious disease specialists,
pneumologists and radiologists blinded to PCR results reviewed patient records, including computed tomography and day 28 follow up, to
categorize ﬁnal diagnostic probability of CAP as deﬁnite, probable, possible, or excluded. Among the 254 patients enrolled, 78 (31%) had
positive PCR, which detected viruses in 72/254 (28%) and intracellular bacteria in 8 (3%) patients. PCR was positive in 44/125 (35%)
patients with deﬁnite CAP and 21/83 (25%) patients with excluded CAP. The most frequent organisms were inﬂuenza A/B virus in 27
(11%), rhinovirus in 20 (8%), coronavirus in seven (3%), respiratory syncytial virus in seven (3%) and Mycoplasma pneumoniae in eight (3%)
of 254 patients. Proportion of rhinovirus was higher in patients with excluded CAP compared with other diagnostic categories (p = 0.01).
No such difference was observed for inﬂuenza virus. Viruses seem common in adults attending emergency departments with suspected
CAP. A concomitant clinical, radiological and biological analysis of the patient’s chart can contribute to either conﬁrm their role, or suggest
upper respiratory tract infection or shedding. Their imputability and impact in early management of CAP deserve further studies.
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nized as a leading cause of hospital admission and death amongious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Das et al. Viruses in adult CAP 608.e2adults in industrialized countries [1] and one of the most
common infectious diseases encountered in emergency de-
partments (ED). Its annual incidence is estimated at 600 cases
per 100 000 inhabitants, which represents in France around
300 000 cases per year causing 3500–11 000 annual deaths,
particularly in the elderly population.
Currently, the diagnosis of CAP is heavily dependent on
clinical and radiological ﬁndings, some of which are largely non-
speciﬁc and of unknown aetiology [2–5], and treatment re-
mains in most cases empirical [6–8]. The conventional micro-
biological techniques, such as culture, serology, antigen
detection, have practical challenges, notably, complex technol-
ogy, poor sensitivity and prolonged turnaround time. Since the
advent of PCR, the advances in these new molecular techniques
have shown their applicability to improve the detection of
agents causing various types of infections. The multiplex PCR
method allows the potential ampliﬁcation of many nucleic acid
targets within a single reaction and has proven to be an
attractive diagnostic method for multi-pathogen detection in
respiratory tract infections [9,10].
In ED, timely and accurate diagnosis is crucial for treat-
ment decisions and the outcome of patients; it has been
advocated that the prognosis of CAP depends on the imme-
diate initiation of speciﬁc treatment no later than 8 h after
diagnosis [11]. We present here the identiﬁcation of infec-
tious agents using multiplex PCR in adult patients with sus-
pected CAP visiting EDs in France within the framework of
the ESCAPED study, a prospective, open-label, multicentre
impact measurement study of thoracic computed tomography
(CT) scans.Material and methodsThe primary objective of the present microbiological study was
to determine the prevalence of infectious agents (viruses and
bacteria) in nasopharyngeal (NP) swabs using multiplex PCR in
adults presenting with clinically suspected non-severe CAP. The
study also aimed to describe detected pathogens according to
the probability of diagnosis of CAP.
Context and design
The ESCAPED study was conducted in four university hospitals
(Bichat, Cochin, Pitié-Salpêtrière and Tenon) in Paris, France.
The study was approved by the ethics committee (Comité de
Protection des Personnes—CPP 1, Paris, France) and patients
gave written informed consent. Consecutive adult patients
(18 years) presenting to the hospital EDs with a clinical sus-
picion of non-severe CAP (classes 1 and 2 on the CRB65 score)
were prospectively enrolled. Clinical suspicion of CAP wasClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inbased on investigator’s own judgement and had to fulﬁl the
following criteria: new onset of systemic features (at least one
among sweat, fever, chills, aches and pain, temperature 38°C)
and symptoms of an acute lower respiratory tract illness (at
least one among: cough, sputum production, dyspnoea, chest
pain, altered breathing sounds).
An expert adjudication committee comprising a senior in-
fectious disease specialist, pneumologist and radiologist
reviewed patient records using all clinical data including day 28
follow up, radiological (thoracic X-ray and CT scan performed
at ED admission), and laboratory ﬁndings to assess the diagnosis
of CAP a posteriori. They jointly established the diagnosis of
CAP and a ﬁnal diagnostic probability according to four cate-
gories—deﬁnite, probable, possible, and excluded CAP. The
committee was blinded to PCR results.
Microbiological samples
Systematic NP swabs were collected at enrolment from the
nose, and also the throat in a sub-population of patients, and
placed in a Middle Virocult MWE (Sigma, St Louis, MO, USA)
transport medium. Samples were kept at room temperature
and sent to the virology laboratory of Bichat-Claude Bernard
Hospital as soon as possible after collection. The NP samples
used in this study were not frozen and thawed. The other
samples such as blood, urine and sputum were collected for
bacteriological examinations within the scope of routine care as
indicated by the attending physician.
Multiplex PCR
The RespiFinder-19 assay (Pathoﬁnder, Maastricht, the
Netherlands) was used to detect 15 respiratory viruses—
coronaviruses 229E, NL63, OC43; human metapneumovirus;
inﬂuenza A, A(H1N1)pdm2009 and B viruses, parainﬂuenza
viruses 1, 2, 3 and 4; respiratory syncytial viruses A and B;
rhinovirus; adenovirus; and four intracellular bacteria—
Bordetella pertussis, Chlamydophila pneumoniae, Legionella pneu-
mophila, Mycoplasma pneumoniae— in one reaction. The
RespiFinder-19 analysed the ampliﬁed PCR products by capil-
lary electrophoresis using a DNA analyser (ABI 3130; Applied
Biosystems, Darmststadt, Germany) and provided diagnosis
within 6 h. The multiplex PCR method used in the present
study was validated by the virology lab that participates every
year to the European quality control program for each respi-
ratory virus.
Statistical analysis
Data collected included demographic variables such as gender
and age, clinical signs of CAP, coexisting conditions, severity
score, as assessed by Fine score (12) and biological data, in
particular inﬂammatory biomarkers.fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 608.e1–608.e8
608.e3 Clinical Microbiology and Infection, Volume 21 Number 6, June 2015 CMIContinuous data were compared using Student t test or
analysis of variance. The Mann-Whitney U test or Kruskal-
Wallis method were used for non-parametric comparisons.
For categorical variables, proportions were compared using
chi-squared or Fisher’s exact test. Statistical analyses were
performed using Stata software, version 11.2 (StataCorp, Col-
lege Station, TX, USA).ResultsPatients’ characteristics
In the ESCAPED study, 319 adult patients with suspected
CAP were enrolled between November 2011 and December
2012. Of these, 254 (80%) patients with NP swabs available
were included in the study, of whom, 51% were female, and
with a mean (SD) age of 65 ± 19 years. The baseline char-
acteristics of the 254 PCR study patients are shown in
Table 1. One third (34%) of patients belonged to the Class IV
or Class V of the FINE score (12). The baseline clinical
characteristics of the 65 patients without swab (Non PCR
Group) were not statistically different from those of patients
who underwent PCR assay (PCR Study Group) except
headache (more frequent in patients in PCR Study Group) and
impaired consciousness (more frequent in patients in Non
PCR Group).TABLE 1. Baseline characteristics of the 254 patients enrolled in P
PCR study group
(254 patients), n (%)
PC
(78
Demographic characteristics
Sex, female 130 (51)
Age, years, mean (SD) 65 (19)
Clinical features
Temperature >38 or <36°C 88 (35)
Cough 191 (75)
Chest pain 88 (35)
Sputum production 120 (47)
Dyspnoea 182 (72)
Chills 83 (33)
Headache 47 (19)
Aches and pain 50 (20)
Crepitation (unilateral) 87 (34)
Heart rate >90/min 172 (68)
Respiratory rate >20/min 121 (60)
Coexisting conditions
At least one comorbidity 114 (45)
Neoplastic disease 28 (11)
Congestive cardiac disease 28 (11)
Chronic lung disease 71 (28)
Before ED characteristics
Duration of symptoms before ED,(hours, mean (SD) 173.3 (240.5) 17
Antibiotics before ED 89 (35)
FINE classiﬁcationa
Class I 38 (15)
Class II 73 (29)
Class III 56 (22)
Class IV 68 (27)
Class V 19 (7)
Abbreviations: ED, emergency departments; Neg., negative; Pos., positive. Numbers in bold
The p value was calculated with the use of t test, otherwise chi-squared test was used.
aA prediction rule to assess the severity of community-acquired pneumonia [12].
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Among the 254 patients, 78 (31%) patients had at least one
infectious agent detected (Fig. 1). The baseline characteristics of
the 78 patients were not different from those with negative
PCR results (Table 1) except neoplastic disease was more
frequent in the negative PCR group.
The vast majority of patients (n = 75, 96%) had a single in-
fectious agent, with a total of 81 pathogens detected in these 78
patients. Of the 254 study patients, 72 (28%), had a virus
detected (Table 2). In the 78 patients with positive PCR, the
most prevalent viral pathogens were inﬂuenza A/B virus in 35%,
rhinovirus in 26%, respiratory syncytial virus A/B in 9% and
coronavirus 229E/NL63/OC43 in 9% of patients. Other viruses
identiﬁed were human metapneumovirus, parainﬂuenza viruses
3/4 and adenovirus. The only bacterium detected was
M. pneumoniae in eight, 3% of patients. The seasonal distribu-
tion of the detected pathogens is shown in Fig. 2.
The multiplex PCR detected viruses in both NP samples in
72 (92% concordant results) of the 78 patients with both NP
swabs taken. The central virology laboratory received and
processed 91% (232/254) of NP swabs within 24 h. The
probability of PCR positivity was not inﬂuenced by the time
intervals between NP swab collection and PCR testing. The
PCR positivity rate for viral infection and the agents found were
comparable between NP (20/78) and only nasal (58/176)
samples.CR study according to PCR results
R-positive
patients), n (%)
PCR-negative
(176 patients), (%)
p Value
(PCR-pos. versus PCR-neg.)
37 (47) 93 (53) 0.43
60 (21) 66 (18) 0.06
28 (36) 60 (34) 0.44
72 (92) 119 (68) <0.001
19 (24) 69 (39) 0.03
48 (62) 72 (41) 0.001
58 (74) 124 (71) 0.31
24 (31) 59 (34) 0.34
20 (26) 27 (15) 0.03
24 (31) 26 (15) 0.001
32 (41) 55 (31) 0.17
54 (69) 118 (67) 0.42
43 (68) 78 (56) 0.07
32 (41) 82 (47) 0.41
3 (4) 25 (14) 0.02
8 (10) 20 (11) 1
21 (27) 50 (28) 0.88
1.6 (245.8) 174.0 (238.8) 0.9
34 (44) 55 (31) 0.04
17 (22) 21 (12)
22 (28) 51 (29)
21 (27) 35 (20) 0.06
15 (19) 53 (30)
3 (4) 16 (9)
are p values <0.05.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 608.e1–608.e8
FIG. 1. Flow chart of detection of
infectious agents in nasopharyngeal
swabs by multiplex PCR in the 319
patients included in the ESCAPED
study.
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Among the 254 patients, 49% were classiﬁed as deﬁnite CAP,
7% as probable, 11% as possible and 33% were excluded by the
adjudication committee (Table 3). Although the PCR ﬁndings
were not different according to the diagnosis probability,
among the 125 patients with deﬁnite CAP, 44 (35%) had pos-
itive PCR results and 81 (65%) were PCR negative. Among the
83 patients with excluded CAP, 21 (25%) were PCR positive.
The probability of PCR detection of rhinoviruses was signiﬁ-
cantly higher in excluded CAP than in the other three groups
combined (10/21 (48%) versus 10/57 (18%), respectively, p
0.01), whereas there was no difference in detection of inﬂuenza
viruses (9/21 (43%) versus 18/57 (32%), respectively). Referring
to the category of diagnosis, the sensitivity and speciﬁcity ofTABLE 2. Multiplex PCR detection of virus and bacteria in
nasopharyngeal swabs collected from 78 of the 254 adult
patients enrolled in the PCR study
Type
Patients with positive
PCR (n [ 78) n (%)
Single agent 75 (96)
Inﬂuenza A/B 27 (35)
Rhinovirus 20 (26)
Respiratory syncytial virus A/B 7 (9)
Coronavirus 229E/NL63/OC43 7 (9)
Mycoplasma pneumoniae 6 (8)
Parainﬂuenza virus 3/4 4 (5)
Human metapneumovirus (hMPV) 3 (4)
Adenovirus 1 (1)
Multiple agents 3 (4)
Co229E—Mycoplasma pneumoniae 1 (1)
Coronavirus OC43—hMPV 1 (1)
Rhinovirus—Mycoplasma pneumoniae 1 (1)
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inmultiplex PCR were 35% and 74%, and the positive and negative
predictive values were 56% and 54%, respectively.
Routine bacteriological ﬁndings
Routine bacteriological examinations were available for 190
(75%) of the 254 patients. Bacterial agents were detected in 28
patients, of whom 11 (39%) had a probably non-pulmonary
infection, and 17 (61%) had detection of bacteria with ‘lung
tropism’, possibly associated with CAP (Table 4). They were:
Streptococcus pneumoniae in nine patients; Legionella pneumophila
and other intracellular agents in three patients; and Haemophilus
inﬂuenzae, Branhamella catarrhalis, a Gram-positive coccus,
Mycobacterium tuberculosis, and an Enterobacteriaceae, each in
one patient. Of the 17 patients with bacteria with “lung
tropism”, 11 had deﬁnite and two had probable or possible
CAP according to the experts.
A bacterial–viral co-infection was present in seven (3.6%) of
the 190 patients. The proportion of bacterial documentation
was not different according to antibiotic administration before
admission to ED. Overall, 95 (37%) CAP patients had detection
of a viral or bacterial agent that was possibly responsible for the
CAP.DiscussionThe present study found that approximately one-third of adult
ED patients presenting with suspected CAP had PCR detection
of viruses in the upper respiratory tract, mainly inﬂuenza A/Bfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 608.e1–608.e8
FIG. 2. Seasonal distribution of detected
pathogens in nasopharyngeal swabs by
multiplex PCR in the 319 patients
included in the ESCAPED study. * As
compared with the total number of
samples.
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only M. pneumoniae, although one patient was diagnosed with
CAP due to L. pneumophila by antigenuria detection.
To our knowledge, this is the ﬁrst prospective clinical trial in
ED describing the viruses associated with suspected CAP in
adult patients taking into account an adjudication committee
diagnosis of CAP as ‘reference’ (due to the inadequate accuracy
of conventional diagnostic tests). Of note, the adjudication
committee based its judgement not only on follow-up data, but
also on systematic day 0 thoracic CT scan, which is unique. The
value of 35% PCR-positive patients with deﬁnite CAP is in
agreement with several studies without an adjudicationTABLE 3. PCR ﬁndings according to the adjudication
committee diagnostic probability of community-acquired
pneumonia (CAP) in the 254 adult patients enrolled in the
PCR study
Adjudication
committee
diagnosis of CAP
PCR results, n (%)
Positive Negative Total
Types of agents (n)
Deﬁnite 44 (35)a 81 (65) 125
Inﬂuenza A/B 12
Rhinovirus 6
Respiratory syncytial virus A/B 5
Coronavirus 229E/NL63/OC43 4
Mycoplasma pneumoniaa 6
Parainﬂuenza virus 3/4 4
Human metapneumovirus 3
Adenovirus 1
Multiple agentsa 3
Probable 4 (22) 14 (78) 18
Inﬂuenza A/B 1
Rhinovirus 1
Respiratory syncytial virus A/B 1
Coronavirus 229E/NL63/OC43 1
Possible 9 (32) 19 (68) 28
Inﬂuenza A/B 5
Rhinovirus 3
Coronavirus 229E/NL63/OC43 1
Excluded 21 (25) 62 (75) 83
Inﬂuenza A/B 9
Rhinovirus 10
Respiratory syncytial virus A/B 1
Coronavirus 229E/NL63/OC43 1
Total 78 (31) 176 (69) 254
aIncludes the eight patients with positive PCR for Mycoplasma pneumoniae.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectcommittee, which reported detection of viruses in a substantial
proportion of patients with CAP. Jennings et al. and Johansson
et al. both reported a viral diagnosis in 29% of hospitalized adult
patients with CAP of similar age group (61–70 years) by PCR,
whereas Liu et al. detected 36% viruses in adult outpatients with
CAP and Templeton et al. detected viruses in 56% of adult
patients from outpatient and inpatient departments, of whom
half of the patients were <60 years old [2–4,13]. The most
frequently detected viruses in our study were inﬂuenza A/B virus
and rhinoviruses, as reported in previous studies [14]. Like our
study, these reports addressed patients with an approximately
similar rate, 28–32%, of coexisting conditions. Paediatric studies
identiﬁed viral infections by real-time PCR in 28% of hospitalized
patients, increasing to 50% in those with asthma [14,15]. The
frequency and distribution of viruses detected were slightly
different in two recent studies of patients in intensive care units
and of elderly adults with moderate to severe illness [16,17].
These differences may partly be due to differences in viruses
circulating in the community during the study period or to the
sensitivity and speciﬁcity of diagnostic technology used. The
seasonal distribution of detected pathogens in our study was
similar to that observed in the community French surveillance
network of patients with inﬂuenza-like illness in 2012–2013
(V Enouf, Institut Pasteur, personal communication). All of these
ﬁndings conﬁrm the major changes induced by molecular tech-
niques in describing CAP-associated microorganisms; in com-
parison, a review of 26 prospective studies in ten European
countries (approximately 6000 patients), published in 1998
before the wide use of PCR, found respiratory viruses accounted
for only 8% of patients with CAP [18].
In patients with a deﬁnite CAP diagnosis, the 35% rate of
PCR-positive results has to be balanced with the still high rate
of negative results, which could be explained by other viral,
bacterial or fungal agents that are not included as targets in the
RespiFinder-19 assay. The fact that NP samples are only a proxy
of the infectious agents present deeper in the lung has to be
considered. Whether lower respiratory samples would haveious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 608.e1–608.e8
TABLE 4. Positive bacteriological data from routine assessment in 28 of the 254 adult patients with suspected CAP enrolled in of
the study
PCR detection
of viruses Type of bacteriologial pathogen
Modality of detection
Diagnosis
of CAPa
Respiratory
sample Blood culture Urine antigen Others
PCR positive
Inﬂuenza A virus Streptococcus pneumoniae Blood culture Deﬁnite
Inﬂuenza A virus Escherichia coli; Staphylococcus coagulase negative Ascitic ﬂuid Excluded
Inﬂuenza A virus Gram-positive cocci Sputum Possible
Inﬂuenza A virus Group B streptococcus Urine culture Deﬁnite
Rhino virus Branhamella catarrhalis Sputum Excluded
Rhino virus Escherichia coli Urine culture Deﬁnite
Rhino virus Streptococcus pneumoniae (sputum and urine antigen);
Escherichia coli (sputum culture)
Sputum Urine antigen Deﬁnite
Rhino virus Streptococcus pneumoniae Sputum Excluded
PCR negative
Negative Streptococcus pneumoniae Blood culture Urine antigen Deﬁnite
Negative Other intracellular Serology Deﬁnite
Negative Other intracellular Serology Probable
Negative Mycobacterium tuberculosis Sputum Excluded
Negative Streptococcus pneumoniae Urine antigen Deﬁnite
Negative Escherichia coli Vertebral puncture culture Excluded
Negative Legionella pneumophila Urine antigen Deﬁnite
Negative Other pyogen Blood culture Possible
Negative Enterobacteriaceae Sputum Excluded
Negative Enterobacteriaceae Urine culture Deﬁnite
Negative Other pyogen Urine culture Excluded
Negative Enterobacteriaceae Blood culture Urine culture Excluded
Negative Enteroccoccus sp.; Citrobacter Urine culture Excluded
Negative Streptococcus pneumoniae Sputum Urine antigen Deﬁnite
Negative Haemophilus inﬂuenzae Blood culture Deﬁnite
Negative Streptococcus pyogenes (blood); Escherichia coli (urine) Blood culture Urine culture Possible
Negative Enterobacteriaceae Blood culture Excluded
Negative Streptococcus pneumoniae Urine antigen Deﬁnite
Negative Streptococcus pneumoniae Urine antigen Deﬁnite
Streptococcus pneumoniae Blood culture Urine antigen Deﬁnite
aAdjudication committee diagnosis of CAP.
CMI Das et al. Viruses in adult CAP 608.e6facilitated imputability and given fewer negative results has to be
studied in patients with more severe conditions that allow for
invasive diagnostic investigations [16]. It is important to admit
that multiplex PCR may have different analytical sensitivities for
different viruses, which would affect the diagnostic yield. It is
interesting to underline that the eight patients with PCR-
detected M. pneumoniae had deﬁnite CAP, reinforcing the in-
terest of this test in the context of M. pneumoniae epidemics.
The 25% PCR-positive patients among those with an
excluded diagnosis of CAP might be explained by the fact that
the infection was localized in the bronchi and the upper res-
piratory tract and did not affect the pulmonary parenchyma.
This could also be explained by the PCR detection of viral
shedding in patients with other diseases mimicking CAP
symptoms [19]. In our study, the higher proportion of rhino-
viruses in patients with excluded CAP suggests that at least part
of these rhinoviruses were either viral shedding or could be
associated with limited upper respiratory tract infection, as
suggested previously in symptomatic and asymptomatic chil-
dren and adults [20–22]. The seasonal distribution of inﬂuenza
A/B virus detection and the similar proportion in excluded and
non-excluded CAP suggest that pneumonia is not the primary
manifestation of inﬂuenza, as already known [23]. Another
hypothesis for this high rate of positive PCR in excluded CAPClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inmay be that some patients with minimal or early lesions of CAP
could present with a normal CT scan, as has been known for a
long time for chest X-rays.
The epidemiology of CAP in adults has probably changed in
recent years because of the indirect impact of pneumococcal
conjugate vaccines in children [24]. However, establishing the
aetiology of CAP remains difﬁcult and the imputability of
pathogens detected in the upper respiratory tract remains
questionable. As in the present study, no cause is determined in
half or more of the patients. Even considering the limit related
to the routine non-standardized sampling for bacterial in-
vestigations in the study, Streptococcus pneumoniae was the most
commonly identiﬁed bacteria associated with CAP, as is
generally recognized. The rate of detection of other bacteria,
and atypical agents was similar to that reported in a recent
review [24]. Respiratory viruses, particularly inﬂuenza virus and
respiratory syncytial virus, are commonly detected in patients
with CAP as described here [14]. However, it remains chal-
lenging to differentiate viral CAP from mixed-infection or
bacterial CAP. It is a hypothesis that the increasing recognition
(15–54%) of viruses as a cause of CAP in adults may reﬂect
advances in viral detection by PCR-based testing. Better ways to
diagnose viral CAP would increase the use of targeted antiviral
therapies. Speciﬁcally, detection of inﬂuenza virus should leadfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 608.e1–608.e8
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of symptoms, which has been shown to improve prognosis
[23]. It can be useful to establish the virological diagnosis for
epidemiological purposes in hospitalized patients who may
require infection control measures to prevent nosocomial
transmission, especially in the case of a new and/or contagious
virus outbreak, such as the recent Middle East respiratory
syndrome coronavirus outbreak [25]. Whether the rapid viral
diagnosis is likely to change individual antibiotic management
and reduce antibiotic overuse has to be studied [24,26].
Nevertheless, the relatively low sensitivity of the test and the
high cost issues need to be addressed before widespread use of
the multiplex PCR method.
The current study had several limitations. The multiplex PCR
(RespiFinder-19) assay was not performed in real time, a limi-
tation that may have underestimated identiﬁcation of viral agents.
However, this assay is generally considered to be as sensitive as
monoplex PCR, which suggests that such a delay is not a major
determinant of false-negative results [27]. Onemajor issue is that
the PCR test did not include S. pneumoniae, the leading organism
of CAP, as a target [3,24,28,29], which precludes comments on
the respective roles of S. pneumoniae and viruses as CAP agents
in our study. Using sputum samples in adult patients attending
ED, Yang et al. found that PCR assay might be a useful diagnostic
adjunct for clinicians to detect a pneumococcal pneumonia [30].
In summary, viruses in nasopharyngeal samples seem com-
mon in adults attending ED with suspected CAP. A concomitant
clinical, radiological and biological analysis of the patient’s chart
can contribute to either conﬁrm their role in CAP, or suggest
upper respiratory tract infection or shedding. Their imputability
and possible impact in early management of CAP deserve
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